Apraclonidine is a prescription medication used to treat glaucoma. Apraclonidine is also used to prevent or reduce increased pressure in the eye during and after certain types of laser eye surgery. Apraclonidine belongs to a group of drugs called alpha 2 adrenergic agonists. These work to lower the pressure in the eye by decreasing the amount of fluid in it.
This medication comes as an eye drop and is usually applied into the eye 3 times a day.
Common side effects of apraclonidine include red eyes, eye discomfort, teary eyes, and itching.
Apraclonidine can also cause blurred vision. Do not drive or operate heavy machinery until you know how apraclonidine affects you.
Patient Ratings for Apraclonidine
How was your experience with Apraclonidine?
Apraclonidine Cautionary Labels
Uses of Apraclonidine
Apraclonidine is a prescription medication used to treat glaucoma in people who are already taking other medications for it and still have pressure in the eye that is too high.
Apraclonidine is also used to prevent or reduce increased pressure in the eye during and after certain types of laser eye surgery.
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Apraclonidine Brand Names
Apraclonidine may be found in some form under the following brand names:
Apraclonidine Drug Class
Apraclonidine is part of the drug class:
Side Effects of Apraclonidine
Serious side effects have been reported with apraclonidine. See the "Drug Precautions" section.
Common side effects of apraclonidine include the following:
- red eye
- eye discharge
- teary eyes
- itchy eyes
- eye discomfort
- dry mouth
- feeling of something in the eye
- blurred vision
- dry eyes
- swelling of the eyelid
This is not a complete list of apraclonidine side effects. Ask your doctor or pharmacist for more information.
Tell your doctor if you have any side effect that bothers you or that does not go away.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.